<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">SAMHD </span>
   <span class="font15">activity </span>
   <span class="font15">cell </span>
   <span class="font14">Synergy </span>
   <span class="font14">combination </span>
   <span class="font14">drugs </span>
   <span class="font14">drug </span>
   <span class="font14">expression </span>
   <span class="font14">cells </span>
   <span class="font14">efficacy </span>
   <span class="font13">CDK/ </span>
   <span class="font13">HIV- </span>
   <span class="font13">pemetrexed </span>
   <span class="font13">(Figure </span>
   <span class="font13">cancer </span>
   <span class="font13">palbociclib </span>
   <span class="font13">used </span>
   <span class="font12">{border-style </span>
   <span class="font12">&amp;lt; </span>
   <span class="font12">different </span>
   <span class="font12">inhibitors </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">[]. </span>
   <span class="font12">nucleoside </span>
   <span class="font12">antiviral </span>
   <span class="font12">function </span>
   <span class="font12">using </span>
   <span class="font12">dNTP </span>
   <span class="font12">fluorouracil </span>
   <span class="font12">Figure </span>
   <span class="font12">effect </span>
   <span class="font12">inhibitor </span>
   <span class="font12">phosphorylation </span>
   <span class="font12">shown. </span>
   <span class="font11">enhanced </span>
   <span class="font11">infection </span>
   <span class="font11">performed </span>
   <span class="font11">protein </span>
   <span class="font11">replication </span>
   <span class="font11">analogues </span>
   <span class="font11">donors </span>
   <span class="font11">evaluated </span>
   <span class="font11">treatment </span>
   <span class="font11">tumor </span>
   <span class="font11">Drug </span>
   <span class="font11">Mean </span>
   <span class="font11">concentrations </span>
   <span class="font11">independent </span>
   <span class="font11">±SD </span>
   <span class="font11">CDK </span>
   <span class="font11">Combination </span>
   <span class="font11">Palbociclib </span>
   <span class="font11">SAMHD, </span>
   <span class="font11">absence </span>
   <span class="font11">anticancer </span>
   <span class="font11">data </span>
   <span class="font11">duplicate </span>
   <span class="font11">measured </span>
   <span class="font11">midostaurin </span>
   <span class="font11">potency </span>
   <span class="font11">relative </span>
   <span class="font11">tested </span>
   <span class="font11">treated </span>
   <span class="font11">GFP </span>
   <span class="font11">HIV </span>
   <span class="font11">SAMHD. </span>
   <span class="font11">anti-folate </span>
   <span class="font11">antimetabolites </span>
   <span class="font11">calculated </span>
   <span class="font11">cycle </span>
   <span class="font11">including </span>
   <span class="font11">macrophages </span>
   <span class="font11">panel) </span>
   <span class="font11">presence </span>
   <span class="font11">types </span>
   <span class="font11">Antagonism </span>
   <span class="font11">MDA-MB- </span>
   <span class="font11">SAMHD-depleted </span>
   <span class="font11">Thus, </span>
   <span class="font11">activation </span>
   <span class="font11">cancer, </span>
   <span class="font11">number </span>
   <span class="font11">pharmacological </span>
   <span class="font11">px; </span>
   <span class="font11">response </span>
   <span class="font11">results </span>
   <span class="font11">reverse </span>
   <span class="font11">values </span>
   <span class="font11">viral </span>
   <span class="font11">{font-family </span>
   <span class="font11">(Table </span>
   <span class="font11">Inhibition </span>
   <span class="font11">MDMs </span>
   <span class="font11">Pemetrexed </span>
   <span class="font11">Table </span>
   <span class="font11">Vpx </span>
   <span class="font11">affecting </span>
   <span class="font11">combinations </span>
   <span class="font11">compounds </span>
   <span class="font11">cytotoxic </span>
   <span class="font11">font-size </span>
   <span class="font11">index </span>
   <span class="font11">indicated </span>
   <span class="font11">intracellular </span>
   <span class="font11">lines </span>
   <span class="font11">mechanism </span>
   <span class="font11">modulation </span>
   <span class="font11">pool </span>
   <span class="font11">previously </span>
   <span class="font11">restriction </span>
   <span class="font11">showed </span>
   <span class="font11">shown </span>
   <span class="font10">&amp;gt; </span>
   <span class="font10">(A) </span>
   <span class="font10">(B) </span>
   <span class="font10">Antiviral </span>
   <span class="font10">DNA </span>
   <span class="font10">[,]. </span>
   <span class="font10">al.SAMHD </span>
   <span class="font10">antimetabolite </span>
   <span class="font10">degradation </span>
   <span class="font10">dependent </span>
   <span class="font10">described </span>
   <span class="font10">double; </span>
   <span class="font10">expressed </span>
   <span class="font10">highly </span>
   <span class="font10">human </span>
   <span class="font10">lung </span>
   <span class="font10">nucleotide </span>
   <span class="font10">observed </span>
   <span class="font10">regulated </span>
   <span class="font10">research </span>
   <span class="font10">selective </span>
   <span class="font10">significantly </span>
   <span class="font10">(left </span>
   <span class="font10">(right </span>
   <span class="font10">(Δ) </span>
   <span class="font10">(■) </span>
   <span class="font10">*** </span>
   <span class="font10">A). </span>
   <span class="font10">Antimetabolites </span>
   <span class="font10">Fluorouracil </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">MA, </span>
   <span class="font10">Western </span>
   <span class="font10">affected </span>
   <span class="font10">analysis </span>
   <span class="font10">blot </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">clinical </span>
   <span class="font10">concentration </span>
   <span class="font10">days </span>
   <span class="font10">directly </span>
   <span class="font10">enhance </span>
   <span class="font10">enhances </span>
   <span class="font10">factor </span>
   <span class="font10">function. </span>
   <span class="font10">inhibited </span>
   <span class="font10">inhibition </span>
   <span class="font10">obtained </span>
   <span class="font10">percentage </span>
   <span class="font10">primary </span>
   <span class="font10">solid; </span>
   <span class="font10">specific </span>
   <span class="font10">synergistic </span>
   <span class="font10">synergy </span>
   <span class="font10">therapies </span>
   <span class="font10">triphosphohydrolase </span>
   <span class="font10">wild-type </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">µM, </span>
   <span class="font10">(C) </span>
   <span class="font10">(SAMHD) </span>
   <span class="font10">-fold </span>
   <span class="font10">AZT </span>
   <span class="font10">B). </span>
   <span class="font10">Cell </span>
   <span class="font10">Cells </span>
   <span class="font10">Dose </span>
   <span class="font10">IHC </span>
   <span class="font10">Inhibitors </span>
   <span class="font10">MDMs. </span>
   <span class="font10">Pharmacological </span>
   <span class="font10">Relative </span>
   <span class="font10">S). </span>
   <span class="font10">TZM-bl </span>
   <span class="font10">USA) </span>
   <span class="font10">Waltham, </span>
   <span class="font10">[,,]. </span>
   <span class="font10">acid </span>
   <span class="font10">affect </span>
   <span class="font10">antibody </span>
   <span class="font10">antimetabolites. </span>
   <span class="font10">bars), </span>
   <span class="font10">bold </span>
   <span class="font10">breast </span>
   <span class="font10">calculation </span>
   <span class="font10">cells, </span>
   <span class="font10">cellular </span>
   <span class="font10">chemotherapeutic </span>
   <span class="font10">combined </span>
   <span class="font10">compared </span>
   <span class="font10">condition. </span>
   <span class="font10">control </span>
   <span class="font10">courier; </span>
   <span class="font10">decreased </span>
   <span class="font10">development </span>
   <span class="font10">domain-containing </span>
   <span class="font10">effective </span>
   <span class="font10">em; </span>
   <span class="font10">expressing </span>
   <span class="font10">expression. </span>
   <span class="font10">limited </span>
   <span class="font10">lines, </span>
   <span class="font10">motif </span>
   <span class="font10">multiple </span>
   <span class="font10">pRb </span>
   <span class="font10">palbociclib, </span>
   <span class="font10">phosphorylation, </span>
   <span class="font10">phosphorylation. </span>
   <span class="font10">potential </span>
   <span class="font10">pt;} </span>
   <span class="font10">purchased </span>
   <span class="font10">role </span>
   <span class="font10">therapeutic </span>
   <span class="font10">tissues </span>
   <span class="font10">transcriptase </span>
   <span class="font10">transcription </span>
   <span class="font10">treat </span>
   <span class="font10">triphosphate </span>
   <span class="font10">tumors </span>
   <span class="font10">viability </span>
   <span class="font10">virus </span>
  </p>
 </body>
</html>
